title: Vitiligo: a potential autoimmune sequela of DRESS syndrome.
authors.affiliation: Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California Los Angeles, BOX 951750, 200 Medical Plaza, Suite 450, Los Angeles, CA, 90095-1750, U.S.A.
authors.forename: S
authors.initials: S
authors.lastname: Lonowski
authors.affiliation: Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California Los Angeles, BOX 951750, 200 Medical Plaza, Suite 450, Los Angeles, CA, 90095-1750, U.S.A.
authors.forename: J
authors.initials: J
authors.lastname: Hau
authors.affiliation: Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California Los Angeles, BOX 951750, 200 Medical Plaza, Suite 450, Los Angeles, CA, 90095-1750, U.S.A. sworswick@mednet.ucla.edu.
authors.forename: S
authors.initials: S
authors.lastname: Worswick
mesh_terms: D000208:Acute Disease; D000279:Administration, Cutaneous; D019980:Amoxicillin-Potassium Clavulanate Combination / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D003879:Dermatologic Agents / Q000008:administration & dosage; D063926:Drug Hypersensitivity Syndrome; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008875:Middle Aged; D009824:Ointments; D012852:Sinusitis / Q000188:drug therapy*; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives; D014820:Vitiligo / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D009824:Ointments; D019980:Amoxicillin-Potassium Clavulanate Combination; C117268:pimecrolimus; D016559:Tacrolimus